Authors: MCINTOSH KR LINSLEY PS BACHA PA DRACHMAN DB

Citation: Kr. Mcintosh et al., IMMUNOTHERAPY OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS - SELECTIVE EFFECTS OF CTLA4IG AND SYNERGISTIC COMBINATION WITH AN IL2-DIPHTHERIA TOXIN FUSION PROTEIN, Journal of neuroimmunology, 87(1-2), 1998, pp. 136-146

Authors: YANG BZ MCINTOSH KR DRACHMAN DB

Citation: Bz. Yang et al., HOW SUBTLE DIFFERENCES IN MHC CLASS-II AFFECT THE SEVERITY OF EXPERIMENTAL MYASTHENIA-GRAVIS, Clinical immunology and immunopathology, 86(1), 1998, pp. 45-58

Authors: DRACHMAN DB MCINTOSH KR LINSLEY PS BACHA PA DRACHMAN DB

Citation: Db. Drachman et al., IMMUNOTHERAPY OF EXPERIMENTAL MYASTHENIA-GRAVIS - SELECTIVE EFFECTS OF CTLA4IG AND SYNERGISTIC COMBINATION WITH AN IL-2 DIPHTHERIA-TOXIN FUSION PROTEIN, Annals of neurology, 42(3), 1997, pp. 229-229

Authors: MCINTOSH KR DRACHMAN DB

Citation: Kr. Mcintosh et Db. Drachman, INDUCTION OF APOPTOSIS INACTIVATED T-CELL BLASTS BY SUPPRESSOR MACROPHAGES - A SEMI-SELECTIVE TREATMENT FOR MYASTHENIA-GRAVIS, The FASEB journal, 10(6), 1996, pp. 2052-2052

Authors: MCINTOSH KR LINSLEY PS DRACHMAN DB

Citation: Kr. Mcintosh et al., IMMUNOSUPPRESSION AND INDUCTION OF ANERGY BY CTLA4IG IN-VITRO - EFFECTS ON CELLULAR AND ANTIBODY-RESPONSES OF LYMPHOCYTES FROM RATS WITH EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, Cellular immunology, 166(1), 1995, pp. 103-112